Renaissance Technologies’s PLx Pharma Inc. Common Stock PLXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-37,000
| Closed | -$5K | – | 4442 |
|
|
2023
Q1 | $5K | Sell |
37,000
-17,500
| -32% | -$3.56K | ﹤0.01% | 3917 |
|
|
2022
Q4 | $9K | Buy |
+54,500
| New | +$22.8K | ﹤0.01% | 4042 |
|
|
2021
Q3 | – | Sell |
-208,983
| Closed | -$2.88M | – | 3973 |
|
|
2021
Q2 | $2.88M | Sell |
208,983
-69,568
| -25% | -$824K | ﹤0.01% | 2004 |
|
|
2021
Q1 | $2.52M | Buy |
278,551
+139,468
| +100% | +$1.02M | ﹤0.01% | 2070 |
|
|
2020
Q4 | $768K | Buy |
139,083
+61,400
| +79% | +$272K | ﹤0.01% | 2630 |
|
|
2020
Q3 | $251K | Buy |
77,683
+3,700
| +5% | +$12.4K | ﹤0.01% | 3055 |
|
|
2020
Q2 | $240K | Sell |
73,983
-417
| -0.6% | -$1.26K | ﹤0.01% | 3112 |
|
|
2020
Q1 | $167K | Buy |
74,400
+4,289
| +6% | +$19.6K | ﹤0.01% | 3132 |
|
|
2019
Q4 | $306K | Buy |
70,111
+1,400
| +2% | +$6.58K | ﹤0.01% | 3067 |
|
|
2019
Q3 | $350K | Buy |
68,711
+4,000
| +6% | +$23.3K | ﹤0.01% | 2991 |
|
|
2019
Q2 | $466K | Buy |
64,711
+6,099
| +10% | +$33.1K | ﹤0.01% | 3018 |
|
|
2019
Q1 | $308K | Buy |
58,612
+14,900
| +34% | +$72.9K | ﹤0.01% | 3083 |
|
|
2018
Q4 | $67K | Buy |
43,712
+2,000
| +5% | +$7.13K | ﹤0.01% | 3268 |
|
|
2018
Q3 | $169K | Buy |
41,712
+2,400
| +6% | +$9.03K | ﹤0.01% | 3178 |
|
|
2018
Q2 | $153K | Buy |
39,312
+1,100
| +3% | +$4.49K | ﹤0.01% | 3105 |
|
|
2018
Q1 | $128K | Buy |
38,212
+5,700
| +18% | +$36.1K | ﹤0.01% | 3239 |
|
|
2017
Q4 | $224K | Buy |
32,512
+10,000
| +44% | +$69.4K | ﹤0.01% | 3103 |
|
|
2017
Q3 | $145K | Buy |
+22,512
| New | +$144K | ﹤0.01% | 3055 |
|
|
2016
Q4 | – | Sell |
-5,275
| Closed | -$612K | – | 3533 |
|
|
2016
Q3 | $612K | Buy |
5,275
+800
| +18% | +$78K | ﹤0.01% | 2751 |
|
|
2016
Q2 | $355K | Buy |
4,475
+1,237
| +38% | +$107K | ﹤0.01% | 2900 |
|
|
2016
Q1 | $246K | Buy |
3,238
+1,100
| +51% | +$69.9K | ﹤0.01% | 3033 |
|
|
2015
Q4 | $192K | Buy |
2,138
+413
| +24% | +$39.6K | ﹤0.01% | 3004 |
|
|
2015
Q3 | $193K | Buy |
+1,725
| New | +$199K | ﹤0.01% | 2904 |
|
Other funds holding PLXP
Renaissance Technologies's PLXP Position: Q2 2023 in Review
Renaissance Technologies sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 37,000 shares — an estimated $5K sold.
Renaissance Technologies first reported a position in PLXP in Q3 2015 and held it in 23 quarters. The position peaked at $2.88M in Q2 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.
- Renaissance Technologies reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Renaissance Technologies sold 37,000 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $5K.
- Renaissance Technologies first reported a position in PLx Pharma Inc. Common Stock in Q3 2015 and held it in 23 quarters.
- Renaissance Technologies's PLx Pharma Inc. Common Stock position peaked at $2.88M in Q2 2021.
- 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.